Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia
Clinical Genetics · 2025
DOI: 10.1111/cge.14647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Susann Karlberg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Mulibrey Nanism, Fibrous Dysplasia of Bone, Bone and Bones. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne, Finska Läkaresällskapet, Academy of Finland.
Abstract (Originalsprache)
Mulibrey nanism (MUL) is a monogenic growth disorder caused by mutations in TRIM37 , with pre‐and postnatal growth failure, typical craniofacial features, perimyocardial heart disease, infertility and predisposition to tumors. Clinically, patients are gracile with relative macrocephaly, thin extremities, and narrow shoulders, but the full spectrum of skeletal features remains unknown. We conducted a cross‐sectional study in order to further clarify the skeletal phenotype. We assessed radiographs of the long bones and spine in 33 MUL patients, aged 4.5–48 years (14 females and 19 males, median age 16.7 years) for skeletal features. Hospital records were reviewed for clinical characteristics and fractures. Results confirmed significant skeletal abnormalities related to MUL. Skeletal changes were present in all patients; long bones were slender and bowed with broad metaphyses and narrow diaphysis, the cortices were thick, and medullary cavities were narrow. The vertebral bodies were tall. Fibrous dysplasia was found in 19/33 patients (58%); changes were monostotic in 58% and polyostotic in 42%. Altogether 17/33 patients (52%) had a history of fractures. This study confirms that in addition to short stature, patients with MUL have a specific skeletal dysplasia. Our findings suggest an important role for TRIM37 in cellular functions governing skeletal modelling and remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Folkhälsan Research Center, Helsinki, Finland.
- Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Pediatric Radiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Molecular Medicine and Surgery, Karolinska Institutet and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Förderung
- Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne
- Finska Läkaresällskapet
- Academy of Finland
- The Swedish Childhood Cancer Fund
- Lastentautien Tutkimussäätiö
- Sigrid Juséliuksen Säätiö
- Finnish state funding for university-level health research
Zitieren
APA
Karlberg, S., Toiviainen-Salo, S., Lipsanen-Nyman, M., & Mäkitie, O. (2025). Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia. Clinical Genetics. https://doi.org/10.1111/cge.14647
Vancouver
Karlberg S, Toiviainen-Salo S, Lipsanen-Nyman M, Mäkitie O. Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia. Clinical Genetics. 2025. doi:10.1111/cge.14647
BibTeX
@article{Karlberg2025,
author = {Karlberg, Susann and Toiviainen-Salo, Sanna and Lipsanen-Nyman, Marita and Mäkitie, Outi},
title = {Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14647}
}
EUVIMED